These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 33577749)

  • 1. Chemoproteomic-enabled phenotypic screening.
    Conway LP; Li W; Parker CG
    Cell Chem Biol; 2021 Mar; 28(3):371-393. PubMed ID: 33577749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in identifying protein targets in drug discovery.
    Ha J; Park H; Park J; Park SB
    Cell Chem Biol; 2021 Mar; 28(3):394-423. PubMed ID: 33357463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding chemogenomic space using chemoproteomics.
    Jones LH
    Bioorg Med Chem; 2019 Aug; 27(15):3451-3453. PubMed ID: 31221609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From Phenotypic Hit to Chemical Probe: Chemical Biology Approaches to Elucidate Small Molecule Action in Complex Biological Systems.
    Pasquer QTL; Tsakoumagkos IA; Hoogendoorn S
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33287212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic approaches to small-molecule discovery in chemical biology.
    Wagner BK; Dey M
    Cell Chem Biol; 2021 Mar; 28(3):245. PubMed ID: 33740431
    [No Abstract]   [Full Text] [Related]  

  • 6. Target deconvolution from phenotype-based drug discovery by using chemical proteomics approaches.
    Kubota K; Funabashi M; Ogura Y
    Biochim Biophys Acta Proteins Proteom; 2019 Jan; 1867(1):22-27. PubMed ID: 30392561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoproteomic approaches to drug target identification and drug profiling.
    Bantscheff M; Drewes G
    Bioorg Med Chem; 2012 Mar; 20(6):1973-8. PubMed ID: 22130419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoproteomics-Enabled Covalent Ligand Screening Reveals ALDH3A1 as a Lung Cancer Therapy Target.
    Counihan JL; Wiggenhorn AL; Anderson KE; Nomura DK
    ACS Chem Biol; 2018 Aug; 13(8):1970-1977. PubMed ID: 30004670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient hit and lead compound evaluation strategy based on off-rate screening by surface plasmon resonance.
    Liu L
    J Med Chem; 2014 Apr; 57(7):2843-4. PubMed ID: 24654838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reimagining Druggability Using Chemoproteomic Platforms.
    Spradlin JN; Zhang E; Nomura DK
    Acc Chem Res; 2021 Apr; 54(7):1801-1813. PubMed ID: 33733731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoproteomics: Towards Global Drug Target Profiling.
    Lu KY
    Chembiochem; 2020 Nov; 21(22):3189-3191. PubMed ID: 32935403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target Identification of Compounds from a Cell Viability Phenotypic Screen Using a Bead/Lysate-Based Affinity Capture Platform.
    Tang H; Duggan S; Richardson PL; Marin V; Warder SE; McLoughlin SM
    J Biomol Screen; 2016 Feb; 21(2):201-11. PubMed ID: 26676096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of direct protein targets of small molecules.
    Lomenick B; Olsen RW; Huang J
    ACS Chem Biol; 2011 Jan; 6(1):34-46. PubMed ID: 21077692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping proteome-wide interactions of reactive chemicals using chemoproteomic platforms.
    Counihan JL; Ford B; Nomura DK
    Curr Opin Chem Biol; 2016 Feb; 30():68-76. PubMed ID: 26647369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a σ
    Wilke J; Kawamura T; Xu H; Brause A; Friese A; Metz M; Schepmann D; Wünsch B; Artacho-Cordón A; Nieto FR; Watanabe N; Osada H; Ziegler S; Waldmann H
    Cell Chem Biol; 2021 Jun; 28(6):848-854.e5. PubMed ID: 33567254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying compound efficacy targets in phenotypic drug discovery.
    Schirle M; Jenkins JL
    Drug Discov Today; 2016 Jan; 21(1):82-89. PubMed ID: 26272035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of Modulators of Adipocyte Physiology Using Fully Functionalized Fragments.
    Galmozzi A; Parker CG; Kok BP; Cravatt BF; Saez E
    Methods Mol Biol; 2018; 1787():115-127. PubMed ID: 29736714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability-based approaches in chemoproteomics.
    George AL; Dueñas ME; Marín-Rubio JL; Trost M
    Expert Rev Mol Med; 2024 Apr; 26():e6. PubMed ID: 38604802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BonMOLière: Small-Sized Libraries of Readily Purchasable Compounds, Optimized to Produce Genuine Hits in Biological Screens across the Protein Space.
    Mathai N; Stork C; Kirchmair J
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Photoaffinity Labeling-Based Chemoproteomics Strategy for Unbiased Target Deconvolution of Small Molecule Drug Candidates.
    Thomas JR; Brittain SM; Lipps J; Llamas L; Jain RK; Schirle M
    Methods Mol Biol; 2017; 1647():1-18. PubMed ID: 28808992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.